Risk of Cardiac Arrhythmias in Patients with Late-Onset Pompe Disease—Results from a Long Follow-Up in a Group of 12 Patients and Review of Literature
Open Access
- 12 February 2024
- journal article
- research article
- Published by MDPI AG in Cardiogenetics
- Vol. 14 (1) , 38-50
Abstract
Background. Pompe disease is a rare, severe, autosomal recessive genetic disorder caused by GAA gene mutations, which cause α-1,4-glucosidase enzyme deficiency. There are two forms of Pompe disease based on the age of onset, the infantile and the adult form (LOPD). Cardiac involvement, previously recognized only in infantile cases, is now also reported in adults. Cardiomyopathy remains an exceptional finding while heart rhythm disorders appear to be more frequent. Methods. We retrospectively evaluated cardiac involvement in 12 patients with late-onset Pompe disease (LOPD) followed for an overall period of 143 years (mean 12.7 ± 7.7) using ECG, Holter ECG, and echocardiography. Results. The mean age of patients (M8:F4) at the first visit was 40.7 ± 16.1 (range 14–63) and 53.7 ± 16.9 (range 21–76) at last visit. Conduction delay was present in three patients; one patient developed ascending aorta ectasia but had a history of hypertension, and one patient showed right heart enlargement on echocardiography, probably due to pulmonary hypertension. No patient died during the FU, nor developed cardiomyopathy. Ectopic supraventricular beats and repeated episodes of ablation-resistant atrial fibrillation were observed in only one patient (8.3%) who required PMK implantation. Conclusions. Benefitting from the long follow-up, this study allows us to state that primary myocardial involvement is rare in patients with LOPD, while rhythm disorders are more frequent and require monitoring to avoid the risk of possible life-threatening complications.Keywords
This publication has 62 references indexed in Scilit:
- Long‐term benefit of enzyme replacement therapy with alglucosidase alfa in adults with Pompe disease: Prospective analysis from the French Pompe RegistryJournal of Inherited Metabolic Disease, 2020
- GAA variants and phenotypes among 1,079 patients with Pompe disease: Data from the Pompe RegistryHuman Mutation, 2019
- Extension of the Pompe mutation database by linking disease‐associated variants to clinical severityHuman Mutation, 2019
- Severe Cardiomyopathy as the Isolated Presenting Feature in an Adult with Late-Onset Pompe Disease: A Case Report2016
- Hypertrophic Cardiomyopathy in Pompe Disease Is Not Limited to the Classic Infantile-Onset Phenotype2014
- Asymptomatic/pauci‐symptomatic creatine kinase elevations (hyperckemia)Muscle & Nerve, 2013
- Autophagy and mitochondria in Pompe disease: Nothing is so new as what has long been forgottenAmerican Journal of Medical Genetics Part C: Seminars in Medical Genetics, 2012
- Update of the Pompe disease mutation database with 107 sequence variants and a format for severity ratingHuman Mutation, 2008
- Enzyme replacement therapy in late‐onset Pompe's disease: A three‐year follow‐upAnnals of Neurology, 2004
- Glycogenosis type II (acid maltase deficiency)Muscle & Nerve, 1995